![Saraswati Kenkare-Mitra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 430 676 $ am 31.05.2026
Saraswati Kenkare-Mitra is currently an Independent Director at Unicycive Therapeutics, Inc. since 2023 and a Member of the National Academy of Medicine (United States).
Formerly, Dr. Kenkare-Mitra was President and Head of Research & Development at Alector, Inc. from 2021 to 2025, Senior Vice President-Development Sciences at Genentech, Inc., and Director at both the Association for Women in Science and The Genentech Foundation.
Dr. Kenkare-Mitra earned a doctorate from The University of California, San Francisco.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALECTOR, INC. 0,18 % | 31.03.2026 | 199.387 ( 0,18 % ) | 430 676 $ | 31.05.2026 |
| 14.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 06.09.2023 |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ALECTOR, INC. | Präsident | 22.12.2025 |
Association for Women in Science
 Association for Women in Science Miscellaneous Commercial ServicesCommercial Services Promotes womens activities in all scientific fields, from mentoring to scholarships to job listings | Direktor/Vorstandsmitglied | - |
The Genentech Foundation
 The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
Association for Women in Science
Association for Women in Science Miscellaneous Commercial ServicesCommercial Services Promotes womens activities in all scientific fields, from mentoring to scholarships to job listings | Commercial Services |
The Genentech Foundation
The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Unicycive Therapeutics, Inc.
 Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
